{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:44:11Z","timestamp":1777866251544,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["K01AI139275"],"award-info":[{"award-number":["K01AI139275"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.vaccine.2022.03.031","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T16:51:21Z","timestamp":1647622281000},"page":"2568-2573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders"],"prefix":"10.1016","volume":"40","author":[{"given":"Ousseny","family":"Zerbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharareh","family":"Modaressi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Fireman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew F.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darios","family":"Getahun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"DeStefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.03.031_b0005","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States","volume":"298","author":"Roush","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.03.031_b0010","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1016\/j.vaccine.2021.03.079","article-title":"Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis","volume":"39","author":"Gidengil","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.031_b0015","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.vaccine.2020.01.024","article-title":"The science of vaccine safety: Summary of meeting at Wellcome Trust","volume":"38","author":"Plotkin","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.031_b0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1542\/peds.2014-1079","article-title":"Safety of vaccines used for routine immunization of U.S. children: a systematic review","volume":"134","author":"Maglione","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.03.031_b0025","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1542\/peds.2011-0400","article-title":"Alternative vaccination schedule preferences among parents of young children","volume":"128","author":"Dempsey","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.03.031_b0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamapediatrics.2013.502","article-title":"A population-based cohort study of undervaccination in 8 managed care organizations across the United States","volume":"167","author":"Glanz","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2022.03.031_b0035","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","article-title":"Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007\u20132012","volume":"32","author":"Larson","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.031_b0040","first-page":"65","article-title":"Delayed Vaccination and Related Predictors among Infants","volume":"41","author":"Poorolajal","year":"2012","journal-title":"Iran J Public Health"},{"key":"10.1016\/j.vaccine.2022.03.031_b0045","doi-asserted-by":"crossref","first-page":"S391","DOI":"10.1016\/j.amepre.2015.06.009","article-title":"Vaccine Hesitancy: Causes, Consequences, and a Call to Action","volume":"49","author":"Salmon","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2022.03.031_b0050","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.15585\/mmwr.mm6740a4","article-title":"Vaccination Coverage Among Children Aged 19\u201335 Months - United States, 2017","volume":"67","author":"Hill","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.03.031_b0055","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.15585\/mmwr.mm6942a1","article-title":"Vaccination Coverage by Age 24 Months Among Children Born in 2016 and 2017 - National Immunization Survey-Child, United States, 2017\u20132019","volume":"69","author":"Hill","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.03.031_b0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1362361312459111","article-title":"Immunization uptake in younger siblings of children with autism spectrum disorder","volume":"18","author":"Abu Kuwaik","year":"2014","journal-title":"Autism: Int J Res Pract"},{"key":"10.1016\/j.vaccine.2022.03.031_b0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1352\/1944-7558-117.3.233","article-title":"Vaccine-related beliefs and practices of parents of children with autism spectrum disorders","volume":"117","author":"Bazzano","year":"2012","journal-title":"Am J Intellectual Dev Disabilities"},{"key":"10.1016\/j.vaccine.2022.03.031_b0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1542\/peds.2014-2715","article-title":"Geographic clusters in underimmunization and vaccine refusal","volume":"135","author":"Lieu","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.03.031_b0075","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/aje\/kwn263","article-title":"Geographic clustering of nonmedical exemptions to school immunization requirements and associations with geographic clustering of pertussis","volume":"168","author":"Omer","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2022.03.031_b0080","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/0009922812438435","article-title":"Survey of vaccine beliefs and practices among families affected by autism spectrum disorders","volume":"52","author":"Rosenberg","year":"2013","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.vaccine.2022.03.031_b0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.03.031_b0090","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1542\/peds.2006-0678","article-title":"Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine","volume":"118","author":"LeBaron","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.03.031_b0095","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa003077","article-title":"The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine","volume":"345","author":"Barlow","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.03.031_b0100","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001721","article-title":"Combination Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children: A Systematic Review and Meta-analysis of Immunogenicity and Safety","volume":"94","author":"Ma","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2022.03.031_b0105","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1542\/peds.2014-1822","article-title":"Safety of measles-containing vaccines in 1-year-old children","volume":"135","author":"Klein","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.03.031_b0110","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1542\/peds.2007-1578","article-title":"Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children","volume":"121","author":"France","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.03.031_b0115","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.vaccine.2017.02.013","article-title":"Risk factors and familial clustering for fever 7\u201310days after the first dose of measles vaccines","volume":"35","author":"Klein","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.031_b0120","first-page":"1","article-title":"Genetic associations with a fever after measles-containing vaccines","author":"Klein","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.03.031_b0125","article-title":"Parental Risk Factors for Fever in their Children 7\u201310 Days After the First Dose of Measles-Containing Vaccines","author":"Zerbo","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.03.031_b0130","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamapediatrics.2013.2745","article-title":"Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children","volume":"167","author":"Rowhani-Rahbar","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2022.03.031_b0135","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1542\/peds.68.5.650","article-title":"Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children","volume":"68","author":"Cody","year":"1981","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.03.031_b0140","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0264-410X(02)00770-3","article-title":"Systematic review of the effects of pertussis vaccines in children","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.031_b0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(84)90061-8","article-title":"Development of a pertussis component vaccine in Japan","volume":"1","author":"Sato","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.03.031_b0150","first-page":"260","article-title":"ACIP Releases 2017 Childhood Immunization Recommendations","volume":"95","author":"Savoy","year":"2017","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.vaccine.2022.03.031_b0155","first-page":"767","article-title":"MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project","volume":"100","author":"Davis","year":"1997","journal-title":"Vaccine Saf Datalink Team Pediatrics"},{"key":"10.1016\/j.vaccine.2022.03.031_b0160","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1542\/peds.2011-3198","article-title":"Measles-containing vaccines and febrile seizures in children age 4 to 6 years","volume":"129","author":"Klein","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.03.031_b0165","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/21645515.2018.1554971","volume":"15","author":"Group MMRS","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.03.031_b0170","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.vaccine.2009.02.044","article-title":"Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age","volume":"27","author":"Halperin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.031_b0175","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-virology-092818-015515","article-title":"The MMR Vaccine and Autism","volume":"6","author":"DeStefano","year":"2019","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.vaccine.2022.03.031_b0180","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/M18-2101","article-title":"Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study","volume":"170","author":"Hviid","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2022.03.031_b0185","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.290.13.1763","article-title":"Association between thimerosal-containing vaccine and autism","volume":"290","author":"Hviid","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.03.031_b0190","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1001\/jama.2015.3077","article-title":"Autism occurrence by MMR vaccine status among US children with older siblings with and without autism","volume":"313","author":"Jain","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.03.031_b0195","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jamapediatrics.2018.0082","article-title":"Vaccination Patterns in Children After Autism Spectrum Disorder Diagnosis and in Their Younger Siblings","volume":"172","author":"Zerbo","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2022.03.031_b0200","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1016\/j.vaccine.2015.07.037","article-title":"Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States population","volume":"33","author":"Sukumaran","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.031_b0205","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s10803-015-2358-0","article-title":"Validation of Autism Spectrum Disorder Diagnoses in Large Healthcare Systems with Electronic Medical Records","volume":"45","author":"Coleman","year":"2015","journal-title":"J Autism Dev Disord"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22003310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22003310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:18:13Z","timestamp":1777537093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22003310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":41,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0264410X22003310"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}